Invitrogen™ Human BCAS4 Synthetic Peptide
BCAS4 Synthetic Peptide, PEP-1021, from Invitrogen.
- Gene ID (Enter)
- 55653
- Species
- Human
- Purification method
- Purified
- Accession number
- Q8TDM0
- Common name
- Human BCAS4
- Brand
- Invitrogen
BCAS4 Synthetic Peptide, PEP-1021, from Invitrogen.
BCAS4 Synthetic Peptide, PEP-1021, from Invitrogen.
The Breast carcinoma amplified sequence (BCAS4) gene is localized to 20q13, a region that is often amplified in breast cancers. It was isolated by the cloning of a highly overexpressed 1.3 kb transcript from the fusion of the last two exons of the BCAS3 and BCAS4 genes. This BCAS3-BCAS4 fusion transcript is only found in the MCF7 cell line, but the BCAS4 gene is also overexpressed in nine of thirteen breast cancer cell lines. The role of BCAS4 is unknown but its mRNA is highly expressed in thymus, spleen, kidney, brain, and placenta, suggesting BCAS4 plays other roles in multiple tissues.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15275019 |
| Specifications | |
| Gene ID (Enter) | 55653 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q8TDM0 |
| Common name | Human BCAS4 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | BCAS4 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1021 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |